34956-31-5

Basic information

• Product Name: Acetamide,N-(4-acetyl-3-methylphenyl)-
• Synonyms: m-Acetotoluidide,4'-acetyl- (6CI)
• CAS NO: 34956-31-5
• Molecular Formula: C₁₁H₁₃NO₂
• Molecular Weight: 191.23
• Product Categories: Aromatic Acetophenones & Derivatives (substituted)
• Mol File: 34956-31-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 137-140 °C(lit.)
• Boiling Point: 384.475 °C at 760 mmHg
• Flash Point: 166.507 °C
• Appearance: /
• Density: 1.123 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• PKA: 14.60±0.70(Predicted)
• CAS DataBase Reference: Acetamide,N-(4-acetyl-3-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide,N-(4-acetyl-3-methylphenyl)-(34956-31-5)
• EPA Substance Registry System: Acetamide,N-(4-acetyl-3-methylphenyl)-(34956-31-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37
• WGK Germany: 3
• Hazardous Substances Data: 34956-31-5(Hazardous Substances Data)

Usage

Uses

4′-Acetamido-2′-methylacetophenone may be used in the preparation of 4-amino-2-methylacetophenone by acid hydrolysis.

General Description

4′-Acetamido-2′-methylacetophenone (4-acetamido-2-methylacetophenone) can be prepared by treating m-methylacetanilide with acetyl chloride in the presence of aluminum chloride in carbon disulfide.

Upstream product

• 75-36-5 acetyl chloride 
• 537-92-8 3-Methylacetanilide 

Downstream Products

• 34956-30-4 N-(3-methyl-4-(2-(4-morpholinyl)-2-thioxoethyl)phenyl)acetamide 
• 34841-55-9 2-(4-amino-2-methylphenyl)acetic acid 
• 1076188-17-4 (E)-1-(4-amino-2-methylphenyl)-3-(4-hydroxy-3-methylphenyl)prop-2-en-1-one 
• 1076188-42-5 (E)-N-(4-(3-(4-hydroxy-3-methylphenyl)acryloyl)-3-methylphenyl)acetamide 
• 1086626-76-7 (E)-1-(4-amino-2-methylphenyl)-3-(3-methyl-1H-indazol-5-yl)prop-2-en-1-one 
• 98-86-2 acetophenone 
• 38177-98-9 2-methyl-4-aminoacetophenone 

Relevant articles and documents

-

-

Doxepin analogs and methods of use thereof

The invention relates to novel antihistamines and methods of modulating sleep by administering a doxepin analog or a pharmaceutically effective salt thereof.